Tsilimigras DI, Brodt P, Clavien PA, Muschel RJ, et al. Liver metastases. Nat Rev Dis Primers. 2021;7:27.

Article  PubMed  Google Scholar 

Blanco Dumarco R, Marques Fonseca G, Ferreira Coelho F, Birk Jeismann V, et al. Multiple colorectal liver metastases resection can offer long-term survival: the concept of a chronic neoplastic disease. Surgery. 2023;173:983–90.

Article  Google Scholar 

Schmidt T, Nienhuser H, Kuna C, Klose J, et al. Prognostic indicators lose their value with repeated resection of colorectal liver metastases. Eur J Surg Oncol. 2018;44:1610–8.

Article  PubMed  Google Scholar 

Kumar R, Dennison AR, Robertson V, Jones MJ, et al. Clinical risk scores in the current era of neoadjuvant chemotherapy for colorectal liver metastases. ANZ J Surg. 2018;88:E16–20.

Article  PubMed  Google Scholar 

Spelt L, Andersson B, Nilsson J, Andersson R. Prognostic models for outcome following liver resection for colorectal metastases: a systematic review. Eur J Surg Oncol. 2012;38:16–24.

Article  PubMed  CAS  Google Scholar 

Yuan C, Zeng L, Duan H, Suksatit B. Meta-analysis of the prognostic value of serum carcinoembryonic antigen in patients with colorectal cancer liver metastases after hepatectomy. Eur J Cancer Prev. 2024;33(4):334–46.

Article  PubMed  CAS  Google Scholar 

Tierney JF, Stewart LA, Ghersi D, Burdett S, Sydes MR. Practical methods for incorporating summary time-to-event data into meta-analysis. Trials. 2007;8:16.

Article  PubMed  PubMed Central  Google Scholar 

Faitot F, Faron M, Adam R, Elias D, et al. Two-stage hepatectomy versus 1-stage resection combined with radiofrequency for bilobar colorectal metastases. Ann Surg. 2014;260:822–8.

Article  PubMed  Google Scholar 

Hof J, Wertenbroek MWJLAE, Peeters PMJG, Widder J, et al. Outcomes after resection and/or radiofrequency ablation for recurrence after treatment of colorectal liver metastases. Br J Surg. 2016;103:1055-62.

Kim K-Y, Kim NK, Cha I-H, Ahn JB, et al. Novel methods for clinical risk stratification in patients with colorectal liver metastases. Cancer Res Treat. 2015;47(2):242–50.

Article  PubMed  Google Scholar 

Neofytou K, Giakoustidis A, Mudan S. CALy Prognostic Score (CEA, ALP, Lymphocyte count) as a predictor of survival after hepatectomy for liver-only colorectal metastases. J BUON. 2015;20(3):746–55.

PubMed  Google Scholar 

Brudvik KW, Mise Y, Chung H, Chun S, et al. RAS mutation predicts positive resection margins and narrower resection margins in patients undergoing resection of colorectal liver metastases. Ann Surg Oncol. 2016;23(8):2635–43.

Article  PubMed  PubMed Central  Google Scholar 

Hokuto D, Nomi T, Yamato I, Yasuda S, et al. The prognosis of liver resection for patients with four or more colorectal liver metastases has not improved in the era of modern chemotherapy. J Surg Oncol. 2016;114:959–65.

Article  PubMed  CAS  Google Scholar 

Sasaki K, Margonis GA, Andreatos N, Kim Y, et al. Combined resection and RFA in colorectal liver metastases: stratification of long-term outcomes. J Surg Res. 2016;206:182–9.

Article  PubMed  Google Scholar 

Neal CP, Nana GR, Jones M, Cairns V, et al. Repeat hepatectomy is independently associated with favorable long-term outcome in patients with colorectal liver metastases. Cancer Med. 2017;6(2):331–8.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Okimoto S, Kobayashi T, Tashiro H, Kuroda S, et al. Significance of the Glasgow prognostic score for patients with colorectal liver metastasis. Int J Surg. 2017;42:209–14.

Article  PubMed  Google Scholar 

Peng J, Li H, Ou Q, Lin J, et al. Preoperative lymphocyte-to-monocyte ratio represents a superior predictor compared with neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios for colorectal liver-only metastases survival. OncoTargets Ther. 2017;10:3789–99.

Article  Google Scholar 

Zhang Y-F, Mao R, Chen X, Zhao J-J, et al. Prognostic analysis of 102 patients with synchronous colorectal cancer and liver metastases treated with simultaneous resection. Chin Med J. 2017;130:1283–9.

Article  PubMed  PubMed Central  Google Scholar 

Loosen SH, Heise D, Dejong CH, Roy S, et al. Circulating levels of osteopontin predict patients’ outcome after resection of colorectal liver metastases. J Clin Med. 2018;7:390.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Marques MC, Ribeiro HSC, Costa WL Jr, de Jesus VHF, et al. Is primary sidedness a prognostic factor in patients with resected colon cancer liver metastases (CLM)? J Surg Oncol. 2018;117:858–63.

Article  PubMed  CAS  Google Scholar 

Yamashita S, Brusvik KW, Kopetz SE, Maru D, et al. Embryonic origin of primary colon cancer predicts pathologic response and survival in patients undergoing resection for colon cancer liver metastases. Ann Surg. 2018;267:514–20.

Article  Google Scholar 

Brudvik KW, Jones RP, Giuliante F, Shindoh J, et al. RAS mutation clinical risk score to predict survival after resection of colorectal liver metastases. Ann Surg. 2019;269:120–6.

Article  Google Scholar 

Chen Q, Wu C, Zhao H, Wu J, et al. Neo-adjuvant chemotherapy-induced neutropenia is associated with histological responses and outcomes after the resection of colorectal liver metastases. J Gastrointest Surg. 2020;24(3):659–70.

Article  PubMed  Google Scholar 

Kim H, Jung HII, Kwon SH, Bae SH, et al. Preoperative neutrophil-lymphocyte ratio and CEA is associated with poor prognosis in patients with synchronous colorectal cancer liver metastases. Ann Surg Treat Res. 2019;96(4):191–200.

Article  PubMed Central  CAS  Google Scholar 

Makhloufi S, Turpin A, el Amrani M, André T, et al. Fong’s score in the era of modern perioperative chemotherapy for metastatic colorectal cancer: a post-hoc analysis of the GERCOR-MIROX phase III trial. Ann Surg Oncol. 2020;27(3):877–85.

Article  PubMed  Google Scholar 

Margonis GA, Buettner S, Andreatos N, Wagner D, et al. Prognostic factors change over time after hepatectomy for colorectal liver metastases. A multi-institutional, international analysis of 1099 patients. Ann Surg. 2019;269:1129-37.

Shin H, Kim CW, Lee JL, Yoon YS, et al. Solitary colorectal liver metastasis after curative intent surgery: prognostic factors affecting outcomes and survival. ANZ J Surg. 2019;89:61–7.

Article  Google Scholar 

Wang Y-Y, Liu Z-Z, Xu D, Liu M, et al. Fibrinogen-albumin ratio index (FARI): a more promising inflammation-based prognostic marker for patients undergoing hepatectomy for colorectal liver metastases. Ann Surg Oncol. 2019;26(11):3682–92.

Article  PubMed  Google Scholar 

Inoue Y, Fujii K, Kagota S, Tomioka A, et al. The management of recurrence within six months after hepatic resection for colorectal liver metastasis. Dig Surg. 2020;37:282–91.

Article  PubMed  Google Scholar 

Kobayashi S, Takahashi S, Takahashi N, Masuishi T, et al. Survival outcomes of resected BRAF V600E mutant colorectal liver metastases: a multicenter retrospective cohort study in Japan. Ann Surg Oncol. 2020;27(9):3307–15.

Article  PubMed  Google Scholar 

Peltonen R, Gramkow MH, Dehlendorff C, Osterlund PJ, et al. Elevated serum YKL-40, IL-6, CRP, CEA, and CA 19–9 combined as a prognostic biomarker panel after resection of colorectal liver metastases. PloS ONE. 2020;15(8): e0236569.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Bai L, Lin Z-Y, Lu Y-X, Chen Q, et al. The prognostic value of preoperative serum lactate dehydrogenase levels in patients underwent curative-intent hepatectomy for colorectal liver metastases: a two-center cohort study. Cancer Med. 2021;10:8005–19.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Boudjema K, Locher C, Sabbagh C, Ortega-Deballon P, et al. Simultaneous versus delayed resection for initially resectable synchronous colorectal cancer liver metastases. A prospective, open-label, randomized, controlled trial. Ann Surg. 2021;273:49-56.

Guo X, Liu Y, Liu L-J, Li J, et al. Development and validation of survival nomograms in colorectal cancer patients with synchronous liver metastases underwent simultaneous surgical treatment of primary and metastatic lesions. Am J Cancer Res. 2021;11(6):2654–69.

PubMed  PubMed Central  Google Scholar 

Kampheus C, Andreatos N, Kruppa J, Buettner S, et al. The optimal cut-off values for tumor size, number of lesions, and CEA levels in patients with surgically treated colorectal cancer liver metastases: an international, multi-institutional study. J Surg Oncol. 2021;123:939–48.

Article  Google Scholar 

Meng Q, Zheng N, Wen R, Sui J, Zhang W. Preoperative nomogram to predict survival following colorectal cancer liver metastasis simultaneous resection. J Gastrointest Oncol. 2021;12(2):556–67.

Article  PubMed  PubMed Central